scholarly journals Recent advances in preventing neurodegenerative diseases

2021 ◽  
Vol 10 ◽  
Author(s):  
Shih-Ching Chou ◽  
Akanksha Aggarwal ◽  
Valina L Dawson ◽  
Ted M Dawson ◽  
Tae-In Kam
Keyword(s):  
Neurodegenerative Diseases ◽  
Recent Advances

Adenovirus in the brain: recent advances of gene therapy for neurodegenerative diseases

1998 ◽  
Vol 55 (4) ◽  
pp. 333-341 ◽  
Author(s):  
M. Barkats ◽  
A. Bilang-Bleuel ◽  
M.H. Buc-Caron ◽  
M.N. Castel-Barthe ◽  
O. Corti ◽  
...  
Keyword(s):  
Gene Therapy ◽  
Neurodegenerative Diseases ◽  
Recent Advances ◽  
The Brain

Recent advances in LC-MS/MS methods to determine endocannabinoids in biological samples: Application in neurodegenerative diseases

2018 ◽  
Vol 1044 ◽  
pp. 12-28 ◽  
Author(s):  
Camila Marchioni ◽  
Israel Donizeti de Souza ◽  
Vinicius Ricardo Acquaro ◽  
José Alexandre de Souza Crippa ◽  
Vitor Tumas ◽  
...  
Keyword(s):  
Neurodegenerative Diseases ◽  
Biological Samples ◽  
Recent Advances

scholarly journals MECHANISMS OF COGNITIVE AND NEUROLOGICAL AGING

2019 ◽  
Vol 3 (Supplement_1) ◽  
pp. S587-S587
Author(s):  
Catherine Kaczorowski
Keyword(s):  
Neurodegenerative Diseases ◽  
Neurological Function ◽  
Biological Aging ◽  
Recent Advances ◽  
Age Related

Abstract This session will focus on recent advances in understanding how biological aging impacts neurological function and risk of developing age-related neurodegenerative diseases.

Potential regulatory mechanisms of lncRNA in diabetes and its complications

2017 ◽  
Vol 95 (3) ◽  
pp. 361-367 ◽  
Author(s):  
Shui-Dong Feng ◽  
Ji-Hua Yang ◽  
Chao Hua Yao ◽  
Si-Si Yang ◽  
Ze-Mei Zhu ◽  
...  
Keyword(s):  
Neurodegenerative Diseases ◽  
Regulatory Mechanisms ◽  
Protein Coding ◽  
Cellular Processes ◽  
Biological Relevance ◽  
Recent Advances ◽  
Non Coding Rnas ◽  
Coding Potential

Long non-coding RNAs (lncRNAs) are transcripts longer than 200 nucleotides without protein-coding potential. Although these molecules were initially considered as “junk products” of transcription without biological relevance, recent advances in research have shown that lncRNA plays an important role, not only in cellular processes such as proliferation, differentiation, and metabolism, but also in the pathological processes of cancers, diabetes, and neurodegenerative diseases. In this review, we focus on the potential regulatory roles of lncRNA in diabetes and the complications associated with diabetes.

scholarly journals Recent Advances and Future Perspectives in the Development of Therapeutic Approaches for Neurodegenerative Diseases

2020 ◽  
Vol 10 (9) ◽  
pp. 633
Author(s):  
Melissa Bowerman
Keyword(s):  
Quality Of Life ◽  
Alzheimer’S Disease ◽  
Neurodegenerative Diseases ◽  
Huntington's Disease ◽  
Neuronal Cells ◽  
Future Perspectives ◽  
Therapeutic Approaches ◽  
Recent Advances ◽  
The Brain

Neurodegenerative diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD) and Huntington’s disease (HD), severely impact the function of neuronal cells in the brain and have devastating consequences on the quality of life of patients and their families [...]

scholarly journals TSE Diagnostics: Recent Advances in Immunoassaying Prions

2013 ◽  
Vol 2013 ◽  
pp. 1-8 ◽  
Author(s):  
Anja Lukan ◽  
Tanja Vranac ◽  
Vladka Čurin Šerbec
Keyword(s):  
Cerebrospinal Fluid ◽  
Neurodegenerative Diseases ◽  
Brain Tissue ◽  
Prion Diseases ◽  
Cellular Prion Protein ◽  
Transmissible Spongiform Encephalopathies ◽  
Post Mortem ◽  
Definite Diagnosis ◽  
Spongiform Encephalopathies ◽  
Recent Advances

Transmissible spongiform encephalopathies (TSEs) or prion diseases are a group of rare fatal neurodegenerative diseases, affecting humans and animals. They are believed to be the consequence of the conversion of the cellular prion protein to its aggregation-prone,β-sheet-rich isoform, named prion. Definite diagnosis of TSEs is determinedpost mortem. For this purpose, immunoassays for analyzing brain tissue have been developed. However, the ultimate goal of TSE diagnostics is anante mortemtest, which would be sensitive enough to detect prions in body fluids, that is, in blood, cerebrospinal fluid, or urine. Such a test would be of paramount importance also for screening of asymptomatic carriers of the disease with the aim of increasing food, drugs, and blood-derived products safety. In the present paper, we have reviewed recent advances in the development of immunoassays for the detection of prions.

Sign in / Sign up

Export Citation Format

Share Document